Biocon mylan

Mylan and Biocon Present Clinical Data on Insulin Glargine at the American Diabetes Association’s...

Bengaluru, Karnataka, India and HERTFORDSHIRE, England, PITTSBURGH, June 10/11, 2017 – Mylan N.V. (NASDAQ, TASE: MYL) and Biocon Ltd. (BSE code: 532523, NSE: BIOCON) today announced the presentation of new data from the insulin...
biocon academy website screenshot

Biocon Academy Introduces First Of Its Kind Career Advancement Program In ‘Clinical Development’ in...

Bengaluru, Karnataka, India, June 08, 2017: Biocon Academy, a CSR initiative of Asia’s leading biotechnology company, has announced the introduction of a unique program in ‘Clinical Development’ in collaboration with Keck Graduate Institute (KGI) in...
medherant website screenshot

Medherant Appoints Sheryl Caswell to Lead Clinical Development of Products Based on its Revolutionary...

Coventry, UK, 6th June 2017 / Sciad Newswire / Medherant Ltd, a University of Warwick spin-out company developing a novel transdermal drug delivery patch technology, is pleased to announce the appointment of Sheryl Caswell as Head...
Pratima Rao

Biocon Appoints Ms. Pratima Rao as Mission Director of Biocon Foundation

Bengaluru, Karnataka, India: June 05, 2017: Biocon Ltd, Asia's premier biopharmaceuticals company, announced today that Ms. Pratima Rao has been appointed as Mission Director & Head of Biocon Foundation*, the CSR arm of the Company....
Vaxon biotech

Vaxon announces results of its Phase IIb lung cancer trial of Vx-001

Paris, France, June 1, 2017 – Vaxon, a biopharmaceutical company developing therapeutic cancer vaccines based on optimized cryptic peptides, announces the results of its Phase IIb trial of Vx-001 in non-small-cell lung cancer (NSCLC)....
imcyse

Imcyse obtains authorization to launch Phase 1b trial in Type 1 diabetes

Liège, Belgium, May 30, 2017 – Imcyse, who develop active specific therapies for the treatment and prevention of severe chronic diseases, today announces that the Belgian and British regulatory authorities have authorized the launch...
medicen

Medicen Paris Region announces 20% business growth in 2016

Paris, May 18, 2017 – Medicen Paris Region, Europe’s leading healthcare cluster, today announces its review of business for the previous year. The 20% growth in activity was reflected in the budget increase, from...
Robocath

Robocath raises €4.7 million ($5.2M) to market its first medical robotic platform, R-one™, in...

Robocath, a medical robotics start-up that designs and develops innovative solutions for the treatment of cardiovascular diseases, today announces the conclusion of a new round of fundraising worth €4.7 million ($5.2M). This round was...
ATUM

ATUM Licenses Gene Design Software to Thermo Fisher Scientific

ATUM (formerly DNA2.0, Inc.) announced today that the company has signed a patent licensing agreement that gives Thermo Fisher Scientific access to the company’s novel gene design platform. "Most people think visually, so seeing a...
fennel reduce postmenopause symptoms

Study Confirms Benefits of Fennel in Reducing Postmenopause Symptoms

CLEVELAND, Ohio (May 17, 2017)—Fennel, an anise-flavored herb used for cooking, has long been known for its health benefits for a variety of issues, including digestion and premenstrual symptoms. A new study confirms that...